Your browser doesn't support javascript.
loading
Risk of eye diseases in osteogenesis imperfecta - A nationwide, register-based cohort study.
Lyster, Marie Louise; Hald, Jannie Dahl; Rasmussen, Malin Lundberg; Grauslund, Jakob; Folkestad, Lars.
Affiliation
  • Lyster ML; Faculty of Health, University of Southern Denmark, Denmark; Department of Endocrinology, Odense University Hospital, Denmark.
  • Hald JD; Department of Internal Medicine and Endocrinology, Aarhus University Hospital, Denmark.
  • Rasmussen ML; Department of Ophthalmology, Odense University Hospital, Denmark.
  • Grauslund J; Department of Ophthalmology, Odense University Hospital, Denmark.
  • Folkestad L; Department of Endocrinology, Odense University Hospital, Denmark; Department of Clinical Research, University of Southern Denmark, Denmark. Electronic address: lfolkestad@health.sdu.dk.
Bone ; 154: 116249, 2022 01.
Article in En | MEDLINE | ID: mdl-34728432
ABSTRACT

BACKGROUND:

Osteogenesis imperfecta (OI) is a hereditary disease caused by affected collagen type 1. Collagen type 1 is an important structural component of the eye. Ocular manifestations in OI are described in literature, but little is known about the risk of eye diseases in OI.

OBJECTIVE:

To investigate the risk of eye diseases in OI.

DESIGN:

A Danish nationwide register-based cohort study based on data from the Danish National Patient Register.

PARTICIPANTS:

All patients registered with an OI diagnosis between January 1977 and December 2018 matched 15 with a reference population on gender and birth month and birth year. MEASUREMENTS Incidence rates (IR) per 1000 patient years and sub-hazard ratio (SHR) for any eye disease, corneal diseases, cataract, refraction disorders, vitreous haemorrhage, retinal detachment, retinopathy, angiopathy, retinal haemorrhage, retinal degeneration, retinal changes, optic nerve disorders, and traumatic eye lesions.

RESULTS:

We identified 907 OI patients (493 women) and 4535 persons (2465 women) in the reference population. The IR for any eye disease was 4.07 [95% CI 3.41-4.85] in the OI cohort and 1.96 [95% CI 1.89-2.12] in the reference cohort. The two diseases with highest incidence was cataract (2.41 [95%CI 1.93-3.03] vs 1.29 [95% CI 1.12-1.47], SHR 1.76 [95% CI 1.34-2.33]) and glaucoma (1.08 [95% CI 0.77-1.51] vs 0.42 [95% CI 0.33-0.54], SHR 2.33 [95% CI 1.55-3.53]). The absolute risk of most other eye diseases was low, but the SHR indicated a higher risk in the OI cohort compared to the reference group showing statistically increased risk of refractive disorders, vitreous haemorrhage, retinal detachment or ruptures, other retinal diseases (i.e., retinopathy, angiopathy, retinal haemorrhage, degeneration, retinal changes), and optic nerve disorders. Corneal diseases and traumatic eye lesions were not statistically significantly increased in OI-patients.

CONCLUSION:

Patients with OI have a higher risk of cataract, refractive disorders, glaucoma, vitreous haemorrhages, retinal detachment/ruptures, retinal diseases, and optic nerve disorders.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis Imperfecta / Eye Diseases Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Bone Journal subject: METABOLISMO / ORTOPEDIA Year: 2022 Document type: Article Affiliation country: Denmark

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteogenesis Imperfecta / Eye Diseases Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Bone Journal subject: METABOLISMO / ORTOPEDIA Year: 2022 Document type: Article Affiliation country: Denmark
...